Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Found 92 record(s)

Req # A-2019-001211

Adverse Drug Reactions (ADRs). Report numbers: E2B_02091013, E2B_02002505, E2B_02002388, E2B_02093588, E2B_02037631, 000721684, E2B_02009483, E2B_02005339, E2B_02012354, E2B_02015506, E2B_02015657, E2B_02112431, E2B_02091166, E2B_02091326, E2B_02050498, E2B_02115333, E2B_02110865, 715417, E2B_02093591, 000716149, E2B_02120345, E2B_02121323, E2B_02096776, E2B_02121456, E2B_02121480, E2B_02120283, E2B_01189101, E2B_02095893, E2B_02050568.

Organization: Health Canada

682 page(s)
February 2023

Req # A-2019-001330

Adverse Drug Reactions (ADRs) for . Report numbers: 000492644, E2B_01131309, E2B_01905011, E2B_01393817, E2B_01393818 E2B_01393819, E2B_01393825, 000684899, 000684971, E2B_00923241, E2B_00934370, E2B_00921359.

Organization: Health Canada

82 page(s)
February 2023

Req # A-2021-000221

Adverse Drug Reactions (ADRs). Report numbers: E2B_03673759, E2B_03703115, E2B_03703624, E2B_03703639, E2B_03706875, 000933420, E2B_02378938, 000934198, 000932984, 000933738, 000934453, 000935436, E2B_03696293, 000935252, E2B_03590665, E2B_03693011, E2B_03646433, E2B_03676955, E2B_03703487, E2B_03564500.

Organization: Health Canada

206 page(s)
February 2023

Req # A-2021-000357

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-103211-284.

Organization: Health Canada

5 page(s)
February 2023

Req # A-2021-000379

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-102743-555.

Organization: Health Canada

6 page(s)
February 2023

Req # A-2021-001185

Adverse Drug Reactions (ADRs) for Veltassa. Report numbers: 000955192, 000955225. ADR for Abilify. Report number: E2B_04230011. ADRs for Abilify maintena. Report numbers: E2B_04319473, 000954222. ADRs for Aripiprazole. Report numbers: E2B_04344156, 000954287, 000956196, 000962479. ADR for Jinarc. Report number: 000955315.

Organization: Health Canada

154 page(s)
February 2023

Req # A-2021-001212

Adverse Drug Reactions (ADRs) for Furosemide. Report numbers: E2B_02329595, E2B_02332753, E2B_02465756, E2B_02666597, E2B_02700545, E2B_02735447, E2B_02862291, E2B_02938406, E2B_03084996, E2B_03107034, E2B_03170465, E2B_03210414, E2B_03224674, E2B_03233626, E2B_03234268, E2B_03260782, E2B_03320166, E2B_03346431, E2B_03349163, E2B_03363133.

Organization: Health Canada

1030 page(s)
February 2023

Req # A-2021-001663

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: 963890, 966033, 966067, 964707, 963933, E2B_04419591, E2B_04424734, 964010, E2B_04461295, E2B_04459289, E2B_04544551, E2B_04420645, E2B_04410627, E2B_04435336, E2B_01854530, E2B_04447602, E2B_04436636, E2B_04458444, E2B_04456635, E2B_04399700.

Organization: Health Canada

509 page(s)
February 2023

Req # A-2021-001664

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_04553348, E2B_02843633, 968020, 967704, 968013, 970085, 968150, 968156, 968232, 968246, 970164, 968660, 968447, 970430.

Organization: Health Canada

132 page(s)
February 2023

Req # A-2021-001881

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-105095-605.

Organization: Health Canada

7 page(s)
February 2023
Date modified: